@OHSU_ID @lstrnad5 As we discussed, immunosuppression will continue to be an issue here even with new mAb vs IL-12, IL-17. Conflicting preclinical data but now some consensus that IL-17 protective early in infection @DLewinsohn @er1nmeer @lstrnad5 https://
IL-17 Production from T Helper 17, Mucosal-Associated Invariant T, and γδ Cells in Tuberculosis Infection and… https://t.co/9n2qUj4AJg https://t.co/YhEv3m3s8m
IL-17 Production from T Helper 17, Mucosal-Associated Invariant T, and γδ Cells in Tuberculosis Infection and Dis... https://t.co/5f56jXO27D